Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Control Release ; 328: 503-513, 2020 12 10.
Artículo en Inglés | MEDLINE | ID: mdl-32860926

RESUMEN

Liposome-supported peritoneal dialysis (LSPD) with transmembrane pH-gradient liposomes was previously shown to enhance ammonia removal in cirrhotic rats and holds promise for the treatment of hyperammonemic crises-associated disorders. The main objective of this work was to conduct the preclinical evaluation of LSPD in terms of pharmacokinetics, ammonia uptake, and toxicology to seek regulatory approval for a first-in-human study. The formulation containing citric acid-loaded liposomes was administered intraperitoneally at two different doses once daily for ten days to healthy minipigs. It was also tested in a domestic pig model of hyperammonemia. The pharmacokinetics of citric acid and 1,2-dipalmitoyl-sn-glycero-3-phosphocholine was linear following intraperitoneal administration of medium and high dose. There was no systemic accumulation following daily doses over ten days. The systemic exposure to phospholipids remained low. Furthermore, the liposome-containing peritoneal fluid contained significantly higher ammonia levels than the liposome-free control, demonstrating efficient ammonia sequestration in the peritoneal space. This was indeed confirmed by the ability of LSPD to decrease plasmatic ammonia levels in artificially induced hyperammonemic pigs. LSPD was well tolerated, and no complement activation-related pseudoallergy reactions were observed. The safety profile, the linear pharmacokinetics of citric acid following repeated administrations of LSPD as well as the linear dose-dependent ammonia sequestration in the peritoneal space provide a strong basis for the clinical investigation of LSPD.


Asunto(s)
Hiperamonemia , Diálisis Peritoneal , Amoníaco , Animales , Líquido Ascítico , Hiperamonemia/tratamiento farmacológico , Liposomas , Ratas , Porcinos , Porcinos Enanos
2.
J Control Release ; 278: 57-65, 2018 05 28.
Artículo en Inglés | MEDLINE | ID: mdl-29601930

RESUMEN

Peritoneal dialysis (PD) performed with transmembrane pH-gradient liposomes was reported to efficiently remove ammonia from the body, representing a promising alternative to current standard-of-care for patients with severe hepatic encephalopathy. In this study, we further characterized the properties of liposome-supported peritoneal dialysis (LSPD) by 1) assessing its in-use stability in the presence of ascitic fluids from liver-disease patients; 2) investigating its interactions with drugs that are commonly administered to acute-on-chronic liver failure patients; and 3) analyzing the in vivo extraction profile of LSPD. We found that LSPD fluid maintained its in vitro ammonia uptake capability when combined with ascitic fluids. The co-incubation of selected drugs (e.g., beta-blockers, antibiotics, diuretics) with LSPD fluids and ammonia resulted in limited interaction effects for most compounds except for two fluoroquinolones and propranolol. However, considering the experimental set-up, these results should be interpreted with caution and confirmatory drug-drug interaction studies in a clinical setting will be required. Finally, metabolite-mapping analysis on dialysates of LSPD-treated rats revealed that the liposomes did not remove important metabolites more than a conventional PD fluid. Overall, these findings confirm that LSPD is a potentially safe and effective approach for treating hyperammonemic crises in the context of acute-on-chronic liver failure.


Asunto(s)
Amoníaco/metabolismo , Líquido Ascítico/metabolismo , Hiperamonemia/terapia , Diálisis Peritoneal/métodos , Insuficiencia Hepática Crónica Agudizada/tratamiento farmacológico , Insuficiencia Hepática Crónica Agudizada/metabolismo , Antagonistas Adrenérgicos beta/administración & dosificación , Antagonistas Adrenérgicos beta/metabolismo , Animales , Antibacterianos/administración & dosificación , Antibacterianos/metabolismo , Diuréticos/administración & dosificación , Diuréticos/metabolismo , Humanos , Concentración de Iones de Hidrógeno , Hiperamonemia/fisiopatología , Liposomas , Masculino , Ratas , Ratas Sprague-Dawley , Índice de Severidad de la Enfermedad
3.
Biomaterials ; 145: 128-137, 2017 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-28858719

RESUMEN

Compared to hemodialysis, peritoneal dialysis represents a more straightforward and less invasive alternative, though current solutions are not as effective. Herein, the feasibility of liposome-supported enzymatic peritoneal dialysis (LSEPD) is explored to increase the functionality of peritoneal dialysis for the model indication acute alcohol poisoning. Enzyme-loaded liposomes (E-Liposomes) containing alcohol metabolizing enzymes, alcohol oxidase and catalase, are developed and their in vitro and in vivo performances investigated. The E-Liposomes outperform the free enzymes in stability, overcoming the thermal instability of alcohol oxidase and enhancing the in vitro ethanol elimination, which is further accelerated by hydrogen peroxide, due to the rapid generation of oxygen by catalase. Compared to the free enzymes, the E-Liposomes exhibit reduced systemic exposure and organ distribution. In a rodent ethanol intoxication model, LSEPD enhances ethanol metabolism as evidenced by an increased acetaldehyde production, ethanol's primary metabolite. In conclusion, LSEPD presents an innovative platform to temporarily enhance xenobiotic metabolism, in view of the improved enzyme stability and peritoneal retention.


Asunto(s)
Oxidorreductasas de Alcohol/metabolismo , Catalasa/metabolismo , Liposomas/química , Diálisis Peritoneal , Animales , Colorantes Fluorescentes/química , Interacciones Hidrofóbicas e Hidrofílicas , Masculino , Ratas Sprague-Dawley , Distribución Tisular
4.
Sci Transl Med ; 7(290): 290ps14, 2015 Jun 03.
Artículo en Inglés | MEDLINE | ID: mdl-26041703

RESUMEN

The number of intoxications from xenobiotics--natural or synthetic foreign chemicals, or substances given in higher doses than typically present in humans--has risen tremendously in the last decade, placing poisoning as the leading external cause of death in the United States. This epidemic has fostered the development of antidotal nanomedicines, which we call "nano-antidotes," capable of efficiently neutralizing offending compounds in situ. Although prototype nano-antidotes have shown efficacy in proof-of-concept studies, the gap to clinical translation can only be filled if issues such as the clinical relevance of intoxication models and the safety profile of nano-antidotes are properly addressed. As the unmet medical needs in resuscitative care call for better treatments, this Perspective critically reviews the recent progress in antidotal medicine and emerging nanotechnologies.


Asunto(s)
Antídotos/uso terapéutico , Sobredosis de Droga/tratamiento farmacológico , Nanotecnología , Intoxicación/tratamiento farmacológico , Humanos
5.
Sci Transl Med ; 6(258): 258ra141, 2014 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-25320233

RESUMEN

Peritoneal dialysis confers therapeutic advantages in patients with renal insufficiency and has proven beneficial in other indications, such as removal of excess metabolites or overdosed drugs. However, it is used in only about 10% of the dialyzed population worldwide, partly owing to the lower clearance rate compared with hemodialysis. We have developed a dialysis medium based on liposomes with a transmembrane pH gradient (basic or acidic aqueous core) that could improve the efficacy of peritoneal dialysis, specifically for the removal of excess metabolites or overdosed drugs. These scavenging vesicles are able to extract ionizable drugs and toxic metabolites into the peritoneal space and can be easily withdrawn from the body at the end of dialysis. This approach was used to successfully remove ammonia from rats with a greater extraction efficiency than traditional peritoneal dialysis, and may therefore prove useful in the treatment of severe hyperammonemia. Liposomal dialysis was also used to concentrate exogenous compounds in the rat peritoneal cavity, allowing for sequestration of several drugs that are frequently involved in overdose in people. In particular, liposomal dialysis counteracted the hypotensive action of the cardiovascular drug verapamil more efficiently than did control dialysis in a rat model of drug overdose. These findings highlight the versatility and advantage of this liposome-based approach for emergency dialysis.


Asunto(s)
Inactivación Metabólica , Liposomas/química , Metaboloma , Diálisis Peritoneal/métodos , Preparaciones Farmacéuticas/metabolismo , Ácidos/metabolismo , Amoníaco/metabolismo , Animales , Sobredosis de Droga/metabolismo , Hemodinámica , Masculino , Preparaciones Farmacéuticas/química , Ratas Sprague-Dawley
6.
Biomaterials ; 33(13): 3578-85, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22330848

RESUMEN

Calcium channel blocker (CCB) overdose is potentially lethal. Verapamil and diltiazem are particularly prone to acute toxicity due to their dual effect on cardiac and vascular tissues. Unfortunately, conventional decontamination measures are ineffective in accelerating blood clearance and, to date, few efforts have been made to develop antidotes. To address the issue, injectable long-circulating liposomes bearing a transmembrane pH-gradient are proposed as efficient detoxifying agents of CCB poisoning. By scavenging the drug in situ, these circulating nanocarriers can restrict its distribution in tissues and hinder its pharmacological effect. In vitro, we showed that liposomes stability in serum and their ability to sequester CCBs could be finely-tuned by modulating their internal pH, surface charge, and lipid bilayer structure. Subsequently, we verified their efficacy in reversing the cardiovascular effects of verapamil in rats implanted with telemetric pressure/biopotential transmitters. In animals orally intoxicated to verapamil, an intravenous injection of the liposomal antidote rapidly attenuated the reduction in blood pressure. Areas under diastolic, systolic, and mean pressures curves were significantly reduced by up to 60% and the time to hemodynamic recovery was shortened from 19 to only 11 h. These findings confirm the protective effect of pH-gradient liposomes against cardiovascular failure after CBB intoxication, and endorse their potential as efficient, versatile antidotes.


Asunto(s)
Bloqueadores de los Canales de Calcio/toxicidad , Sistema Cardiovascular/efectos de los fármacos , Sistema Cardiovascular/patología , Liposomas/farmacología , Animales , Presión Sanguínea/efectos de los fármacos , Sistema Cardiovascular/fisiopatología , Diltiazem/toxicidad , Portadores de Fármacos , Concentración de Iones de Hidrógeno/efectos de los fármacos , Inyecciones Intravenosas , Cinética , Masculino , Ratas , Ratas Sprague-Dawley , Factores de Tiempo , Verapamilo/toxicidad
7.
Comput Methods Biomech Biomed Engin ; 12(1): 95-100, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18651261

RESUMEN

A combined experimental/numerical study was performed to calculate the 3D octahedral shear strain map in a mouse tibia loaded axially. This study is motivated by the fact that the bone remodelling analysis, in this in vivo mouse model should be performed at the zone of highest mechanical stimulus to maximise the measured effects. Accordingly, it is proposed that quantification of bone remodelling should be performed at the tibial crest and at the distal diaphysis. The numerical model could also be used to furnish a more subtle analysis as a precise correlation between local strain and local biological response can be obtained with the experimentally validated numerical model.


Asunto(s)
Remodelación Ósea/fisiología , Modelos Biológicos , Tibia/fisiología , Soporte de Peso/fisiología , Animales , Fuerza Compresiva/fisiología , Simulación por Computador , Módulo de Elasticidad/fisiología , Imagenología Tridimensional/métodos , Masculino , Ratones , Ratones Endogámicos C57BL , Resistencia al Corte , Estrés Mecánico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA